 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Supporting Societies
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsors
|
|
|
|
|
 |
|
|
 |
|
|
|
|
 |
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
 |
 |
|
|
Abstract submission is closed. Thank you for your submission.
*There will be no more extension. |
| ◆General Guidelines | |
| >> | Abstracts should be written in English. |
| >> | Abstract title must be limited to 30 words. |
| >> | The body of abstracts should contain a maximum of 250 words and must be submitted in English. |
| >> | No chart and graphics should be included in the abstract. |
| >> | All abstracts must be submitted online via this official congress website. Please click on the “Abstract Submission” button below to access the abstract submission form. (Abstract sent by Fax or e-mail will not be accepted.) |
| >> | Confirmation of your abstract submission will be sent to your registered e-mail address after submission completion. If you do not receive the confirmation, it indicates that your submission was incomplete and you need to contact at the Program Secretariat at prog-wcmic2015@congre.co.jp |
| >> | It is the responsibility of the corresponding author = first author to review his/her own submitted abstract and correct it if necessary by the abstract submission deadline. The corresponding author = first author is responsible for any typing errors in the abstract. |
| >> | Modifications / cancellation can be made up until the abstract submission deadline,Friday, May 15, 2015. A modification and cancellation shall not be allowed under any circumstances after the abstract submission deadline. |
| ◆Abstract Categories |  |
| Important Points for Abstract Submission At first, please select your presentation style. |
1. Presentation Style |
| (1)Symposium and (2)Sutelite Symposium are only for designated speakers So please select "Poster" |
| (1) | Symposium (Designated speakers only) |
| (2) | Satellite Symposium (Designated speakers only) |
| (3) | Poster |
2. Poster categories
| P1 | Angiogenesis/ lymphangiogenesis/ microvascular remodeling/ injury & repair |
| P2 | Atherosclerosis/ thrombosis/ platelets |
| P3 | Cancer metabolism and microcirculation |
| P4 | Cell signaling: proteins, pathways, and mechanisms |
| P5 | Cell systems and metabolism |
| P6 | Cerebral circulation |
| P7 | Ion channels and transporters |
| P8 | Coronary circulation |
| P9 | Endothelial cell biology |
| P10 | Gasbiology: O2, NO, CO, H2S, and other small size mediators |
| P11 | Imaging |
| P12 | Inflammation/ leukocyte-endothelium interactions/ immune cell trafficking |
| P13 | Instrumentation, methodology, and experimental models |
| P14 | Lymphatic and venular function |
| P15 | Mechanistic impacts of posttranslational modifications |
| P16 | Metabolomics and disease |
| P17 | Microvascular cell signaling pathways |
| P18 | Microvascular development and aging |
| P19 | Microvascular flow regulation/ oxygen delivery/ networks |
| P20 | Microvascular mechanics/ Microvascular modeling/ hemodynamics/ rheology |
| P21 | Microvascular pathophysiology-pharmacology |
| P22 | Neuron-glia-vasculature |
| P23 | Oxidative stress, mitochondrial metabolism and redox |
| P24 | Vascular smooth muscle cells/ Pericytes |
| P25 | Peripheral circulation |
| P26 | Permeability/ fluid & solute exchange/ glycocalyx |
| P27 | Stem cells |
| P28 | Tissue-microvessel interactions/ extracellular matrix |
| P29 | Translational research |
| P30 | Miscellaneous |
| ◆Travel Award (poster applicant only) | ||
| ・ | A limited number of Travel Awards are available to encourage poster applicants of WCMic2015 congress. The grant is JPY150,000 and all travel award recipients have to be presented at the congress. Eligibility to apply for the Travel Award: an individual who is beginning his/her career ≤6 years since award of Ph.D. at the time of the meeting. Step 1:Answer questionnaires from Q4 to Q10 if applicable. Step 2:Make sure to answer Q8 to Q10 when you submit your abstract. You will be notified in early July whether you have been selected as Travel Grant recipient. |
|
| ◆Young Investigators Symposium (poster applicant only) | ||
| ・ | The International Scientific Advisory Committee of the 10th World Congress for Microcirculation (WCMic 2015) invites you to submit your abstract for consideration for an oral presentation in the Young Investigators Symposium (YIS). If you are a member of the Microcirculatory Society (MCS), the European Society for Microcirculation (ESM), the British Society for Microcirculation (BMS) or the Australia & New Zealand Microcirculation Society (ANZMS), please follow the procedures designated by the regional society, i.e., MCS, ESM, BMS or ANZMS. If you are affiliated with an institute in Asia and would like to be considered for participation in the YIS, you must: Step 1: Have submitted an abstract for poster presentation. Step 2: When you submit the abstract, indicate that you would like your abstract to be considered for an oral presentation in the YIS by checking the box. You will be notified in early July whether you have been selected to present in the YIS. Eligibility:Applicants for the Young Investigators Symposium must be; ・a member of a regional Asian Society ・an individual who is beginning her/his career ≤6 years since award of Ph.D. at the time of the meeting In addition, please provide a 1 paragraph summary of employment / activity since award of PhD, grants held, a list of peer-reviewed publications and your email address. |
|
| ◆Early Stage Researcher (ESR) | ||
| ・ | Early Stage Researcher (ESR) is defined as an individual who is beginning his/her career, has less than six years beyond completion of the Ph.D. or has less than three years beyond the initial appointment of junior faculty position at the time of the meeting. | |
| <How to apply> | ||
| ・ | The 10th World Congress for Microcirculation (WCMic 2015) invites you to submit your abstract for consideration of presentation at the Hybrid Symposia. To be considered for presentation, you must: Step 1: Have submitted abstract for poster presentation. Step 2: When you submit the abstract, indicate that you would like your abstract to be considered for the presentation at one of the hybrid symposia listed below by checking the box. You will be notified by the Chair of the appropriate session in August if you have been selected to present at the hybrid symposium. A) Bone microcirculation: a potential therapeutic target (Nicola Brown) B) Microvascular plasticity and developmental priming: impact on human health (Geraldine Clough) C) Inflammation, oxidative stress and microRNAs in vascularization (Jozef Dulak) D) TRP Channels and Vascular Disease (Scott Earley) E) Myeloid Cell Trafficking in Disease (Catherine Hedrick) F) Mechanobiology: Roles of Cellular and Non-Cellular Elements (Gerald Meininger) G) Building vascular networks: determination, randomness and functional control (Axel Pries) H) Platelets: Key mediators of inflammation in the microcirculation (Rolando Rumbaut) |
|
| Ciphertext-based | ||
|
| ◆ID and Password | ||
| ・ | After registering your abstract, you will receive a confirmation by e-mail with your login ID and password codes. | |
| ・ | We cannot inform you of your password and ID for security reasons. Please print out the website after your registration. | |
| ・ | If you wish to make any corrections to your abstract already submitted or wish to delete it, Click “Modification” button and use your personal ID and password. | |
| ◆Notification of Acceptance | ||
| ・ | Notification of Acceptance will be sent to the corresponding author in June, 2015 | |
| ◆Attention | ||
| ・ | The first author or presenter must make a pre-registration when submitting an abstract. | |
| ・ | The first author must be corresponding author. Maximum 20 co-author’s names can be included, and will appear on the printed materials in the submitted order. | |
| ・ | The first author or presenter who cannot make a pre-registration due to some unavoidable reasons must inform the secretariat in advance. | |
| ・ | This abstract submission system works only with the following browsers: Internet Explorer, Firefox, Google Chrome and Safari (ver. 2.0.3 (471.9.2) or later). Please do not use other browsers for abstract submission. | |
| ・ | The first author is responsible for getting agreements from co-authors before submission. | |
| ・ | After the submission period, change of abstract and addition and/or change of authors cannot be made. Please make sure all authors are entered. | |
| ・ | Any submitted abstracts will not be edited or proof-read before printing. The first author is responsible for his/her abstract. | |
| ◆CORRESPONDENCE |
| Program Secretariat of 10th World Congress for Microcirculation (WCMic 2015) c/o Congress Corporation, Kohsai-kaikan Bldg., 5-1 Kojimachi, Chiyoda-ku, Tokyo 102-8481, Japan Phone: +81-3-5216-5318 Fax: +81-3-5216-5552 E-mail:prog-wcmic2015@congre.co.jp |
